• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude CEO: Device tax will have “unintended consequences” | Wall Street Beat

St. Jude CEO: Device tax will have “unintended consequences” | Wall Street Beat

July 19, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

The ever-looming 2.3% medical device tax "will have more impact on businesses than is generally appreciated, St. Jude Medical (NYSE:STJ) CEO Daniel Starks told investors during the company’s earnings call this week.

Starks described a downward spiral of events that will begin Jan. 1, 2013, with giving the federal government a 2.3% cut of every U.S. medical device sale.

"We think that it will reduce the level of investment that medical device companies have available," he said. "We think the reduced level of investment is going to impact jobs and result in reduced jobs."

"We think that the reduced level of investment and the increased outflow of cash to this excise tax will impact company valuations," he added. "And it wouldn’t surprise us to see consolidation of the medical device industry increase during 2013."

Starks further dispelled the arguments put forth by opponents of repealing the tax that the measure, which aims to provide funding for the Affordable Care Act, would represent a "windfall" for device makers in the form of an increased population of insured patients to sell devices to.

"We don’t see a windfall from healthcare reform. Our outlook for market growth is lower as a result of healthcare reform for our particular business," he said.

 June VC deals for med-tech top $418M

Venture capital funding for medical device companies topped $418 million in June 2012, compared with $482 million in June 2011. The infusion was spread over nearly 70 deals, more than any other month in the last 2 years. 
Read more

 GI Dynamics makes moves in Germany, Chile, France
GI Dynamics (ASX:GID) continued its global march, expanding availability of its weight-loss and diabetes treatment devices in Germany, launching the 1st Center of Excellence and 1 commercial centers in Chile and touting 1st use in France. 
Read more

 Globus Medical prices IPO at $16-$18 per share
Spinal devices maker Globus Medical Inc. plans to launch its initial public offering with nearly 11.8 million shares at between $16-$18 apiece.
Read more

 M&A Roundup

  • Florida-based Allezoe Medical merges with HealthWatch Systems for an undisclosed amount

 Analysts’ ups and downs

  • AthenaHealth (NSDQ:ATHN): Citigroup upgrades from "neutral" to "buy" rating, raises price target from $52 to $110
  • C.R. Bard (NYSE:BCR): Barclays maintains “underweight” rating, raises price target from $87 to $101
  • Cyberonics (NSDQ:CYBX): Jeffries raises price target to $58, maintains "buy" rating
  • HeartWare International (NSDQ:HTWR): Goldman Sachs initiates coverage with a “neutral” rating, $93 price target
  • Johnson & Johnson (NYSE:JNJ): Jeffries reiterates “buy” rating, raises price target from $75 to $76; Leerink Swann maintains "outperform" rating, raises price target to $76
  • Smith & Nephew (FTSE:SN, NYSE:SNN): Numis downgrades to "add" from “buy” rating
  • St. Jude Medical (NYSE:STJ): Leerink Swann maintains "outperform" rating, sets ~$46 price target; Jeffries reiterates "hold" rating, raises price target to $40 from $38; Deutsche Bank maintains "buy" rating, reduces price target to $49 from $47
  • Stryker (NYSE:SYK): Leerink Swann maintains “outperform” rating, lowers price target to $66 from $6

Filed Under: News Well, Wall Street Beat Tagged With: GI Dynamics, Globus Medical, stjudemedical

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy